Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway
Sunbin Ling(Blood Center of Zhejiang Province), Yan Li(Dalian Medical University)
Cited by 97
Related Papers
USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
|Molecular Oncology|2017|106
Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines
|Oncology Reports|2014|62
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I
|Cell Death and Disease|2017|60